All In Biotech

Drug Trial Radar · NCT05946941

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome (POETYK SjS-1)

Last checked: Nov 19, 2026Latest source record: Apr 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 774 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

774

Actual

Start

Sep 11, 2023

Primary completion

Nov 18, 2026

Study completion Nov 16, 2028

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Jul 14, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.

Conditions

  • Sjögren's Syndrome

Interventions

  • DeucravacitinibDrug

    Specified dose on specified days

  • PlaceboOther

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in European League Against Rheumatism Sjögren's Syndrome Disease Activity Index (ESSDAI) Score at Week 52Time frame: Baseline, Week 52

Locations

199 sites in 33 countries. Site status is shown where the registry gives one.

  • Local Institution - 0228

    Fullerton, California

  • Local Institution - 0222

    La Palma, California

  • Local Institution - 0218

    San Francisco, California

  • Local Institution - 0203

    Santa Monica, California

  • Local Institution - 0067

    Denver, Colorado

  • Local Institution - 0049

    Clearwater, Florida

  • Local Institution - 0226

    Cooper City, Florida

  • Local Institution - 0223

    Sarasota, Florida

  • Local Institution - 0140

    Augusta, Georgia

  • Local Institution - 0229

    Lawrenceville, Georgia

  • Local Institution - 0174

    Skokie, Illinois

  • Local Institution - 0016

    Kansas City, Kansas

  • Local Institution - 0017

    Baton Rouge, Louisiana

  • Local Institution - 0125

    Monroe, Louisiana

  • Local Institution - 0187

    Baltimore, Maryland

  • Local Institution - 0173

    Boston, Massachusetts

  • Local Institution - 0131

    Eagan, Minnesota

  • Local Institution - 0138

    Summit, New Jersey

  • Local Institution - 0009

    Albuquerque, New Mexico

  • Local Institution - 0184

    Mineola, New York

  • Local Institution - 0224

    Salisbury, North Carolina

  • Local Institution - 0130

    Duncansville, Pennsylvania

  • Local Institution - 0022

    Jackson, Tennessee

  • Local Institution - 0144

    Allen, Texas

  • Local Institution - 0227

    Katy, Texas

  • Local Institution - 0175

    Plano, Texas

  • Local Institution - 0133

    Seattle, Washington

  • Local Institution - 0189

    Spokane, Washington

  • Local Institution - 0137

    CABA, Argentina

  • Local Institution - 0109

    City of Buenos Aires, Argentina

  • Local Institution - 0061

    Córdoba, Argentina

  • Local Institution - 0050

    San Isidro, Alabama, Argentina

  • Local Institution - 0100

    CABA, Buenos Aires, Argentina

  • Local Institution - 0003

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • Local Institution - 0019

    Quilmes, Buenos Aires, Argentina

  • Local Institution - 0026

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Local Institution - 0120

    Woodville South, South Australia, Australia

  • Local Institution - 0117

    Graz, Austria

  • Local Institution - 0087

    Vienna, Austria

  • Local Institution - 0172

    Ghent, Belgium

Showing 40 of 199 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.